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Abstract (now 182 words) 
Physical health deteriorates more rapidly with age among men and women with 
lower socioeconomic status (SES) than among those with higher SES. The biological 
processes underlying these differences are best understood by adopting a life-course 
approach. In this paper we introduce the European LIFEPATH project designed to 
investigate SES and ageing as a phenomenon with two broad stages across life: build-
up and decline. LIFEPATH adopts a study design that integrates social science and 
public health approaches with biology (including molecular epidemiology), using (a) 
national census-based follow-up data to obtain mortality by socio-economic status, 
(b) 17 well-characterised population cohorts, and (c) omics measurements 
(particularly epigenomics). The majority of cohorts include “hard” outcomes 
(diabetes, cancer, CVD, total mortality), and some extensively phenotyped cohorts 
also include measurements of the functional components of healthy ageing, including 
frailty, impaired vision, cognitive function, renal and brain function, osteoporosis, 
sleep disturbances and mental health. All age groups are represented with two birth 
cohorts, one cohort of adolescents and several cohorts encompassing young adults 
(age 18 and above). Furthermore, there is a strong representation of elderly subjects 
in 7 cohorts.  
 
Key words: social inequalities, socioeconomic status, healthy ageing, life-course, omics, 
biology. 
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Introduction 
The striking difference in healthy ageing, quality of life and life expectancy observed between 
individuals from different socioeconomic groups is a major societal challenge that Europe is 
currently facing. Healthy ageing is an achievable goal in society as it is already experienced by 
individuals in the highest socioeconomic groups. Individuals with high socioeconomic status 
(SES) experience much better health and healthier ageing than groups with low SES. Healthy 
ageing is also strongly related to cumulative exposure to harmful events during the life-
course, and particularly in sensitive or critical periods. There is strong evidence that (a) the 
risk of disease is influenced by early exposures, including in utero exposures; (b) the life-
course is characterised by critical periods (during which changes in exposure have long term 
effects on disease risks) and sensitive periods (during which an exposure has stronger effects 
on development and, hence, disease risk than at other times). The LIFEPATH project is an 
example of the integration of social and biological sciences to provide evidence for public 
health policies directed at meeting the challenges that the socioeconomic gradient and other 
factors in healthy ageing represent. The present paper describes the design and some initial 
results.  
Context and rationale 
LIFEPATH is based on a few assumptions that we describe below and have been addressed 
through the design choices we have made. 
 
 
1.  The healthy ageing model  
Socioeconomic differences in health are striking and are seen in all European countries 
(Mackenbach et al., 2008). Physical health deteriorates more rapidly with age for men and 
women from lower socioeconomic groups than among those from higher socioeconomic 
backgrounds. In addition, there is a large amount of evidence that this holds true also for 
mental health (see for instance Melchior et al., 2013). 
This creates a progressively increasing health differential between social groups such that the 
average physical health of a 70-year-old man or woman with high SES is similar to that of a 
person with low SES (occupational grade) who is eight years younger (Chandola, T., Ferrie, J., 
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Sacker, A. and Marmot, M., 2007). These differences, and the biological processes underlying 
them, cannot be understood without adopting a life-course approach. In the project we 
describe below we use the revised Strachan-Sheikh Ben-Shlomo, Y. and Kuh, D., 2002) model 
of life-course functioning (Blane et al, 2013; Kuh, D., 2007, 2014;), to describe ageing over a 
lifetime. This model presents ageing as a phenomenon with two broad stages: build-up and 
decline. The ‘build-up’ stage, from conception and early intra-uterine life to late adolescence 
or early twenties, is characterised by rapid successions of developmentally and socially 
sensitive periods. This stage strongly determines subsequent ageing trajectories as it 
influences the maximum attained level of health. The second stage, starting in early 
adulthood, is a period of 'decline' from maximum attained health to loss of function, overt 
disease and death. Lifestyle and exposures during the second stage can influence the rate at 
which functioning is lost (Figure 1- dashed line). We are aware that this working scheme is a 
simplification and does not incorporate the complex relationships that underlie ageing 
processes, but we use it as a conceptual tool to organize our life-course observations.  
(Figure 1 here) 
 
 
 
2. The complex causal network underlying SES and health 
There is much evidence that low SES across the life-course is associated with poor ageing 
trajectories and early death (Chetty, R. et al, 2016; House, J.S. et al, 2005; Mackenbach, J. et 
al 2008; Stringhini, S. et al, 2010). There is evidence that the impact of SES on ageing is partly 
mediated by risk factors for non-communicable diseases (NCD), but this is not the only 
pathway. Also, the features of low SES in high-income countries have dramatically changed 
over the last century. In Europe, low SES is often associated with food abundance (but of poor 
quality), lack of physical exercise, and psychosocial stress (including sleep deprivation and 
mental problems) (Dugravot, A. et al, 2010; Kivimäki, M. et al, 2002, 2012, 2015; Stringhini, S. 
et al, 2010, 2012;). This adds to the traditional stressors, such as physical fatigue related to 
occupation and housework. Analyses in the Gazel cohort, which is part of Lifepath (Kivimaki, 
M. et al, 2008; Platts et al, 2016) show that demanding jobs were associated with fewer life 
years spent in good health.  
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SES is linked to many determinants of health, including: 1) access to and use of medical care; 
2) access to health information; 3) patterns of unhealthy behaviors (smoking, heavy drinking, 
unhealthy diet, physical inactivity, drug use); 4) exposure to environmental and occupational 
hazards; 5) exposure to stressful life events; 6) access to resources mediating the physiological 
consequences of stress (social relationships and support and  cultural capital); 7) early life 
adverse experiences; 8) age and time-related susceptibilities (Abel, T., 2008; James WP et al. 
1997; Kelly-Irving, M. et al. 2011; Lantz, P.M. et al. 2005; Lynch, J.W. et al. 1997; Mitchell, R. 
et al. 2002; Siegrist, J. et al. 2004; van Doorslaer, E. et al. 2006; ). The Whitehall studies (part 
of LIFEPATH) have shown that the SES gradient in unhealthy ageing and cardiovascular disease 
(CVD) in particular is not completely explained by traditional risk factors, even when they are 
reduced to the lowest levels for the whole population (Kivimäki, M. et al, 2008; Marmot, M. 
et al, 2008). In addition, global changes in the economy are accompanied by rising social 
inequalities. Instability of markets and lack of growth may lead to instability of health 
indicators and of ageing trajectories as well. The issue of social inequalities (and their health 
impact) is increasingly being recognized as a global challenge and priority by the global 
scientific and policy community, as demonstrated by the publication of an issue of the Science 
magazine devoted to socio-economic differentials, their projections, and their impact on 
health (Chin, G. and Culotta, E., 2014; Piketty, T. and Saez, E., 2014).  
 
3. Role of behavioural risk factors 
Though epidemiology has extensively investigated chemical, physical and behavioural risk 
factors (such as smoking, diet, alcohol, physical exercise, and occupational factors), these still 
explain only a fraction of the burden of non-communicable diseases (NCD’s) and of common 
disabilities. For example, a large fraction of breast, colon and prostate cancers is not explained 
by known risk factors, and the causes of common conditions such as cognitive impairment 
are largely unknown. The United Nations 25x25 strategy for NCDs (aiming to reduce mortality 
from NCDs by 25% by the year 2025) lists diabetes/obesity, alcohol, physical exercise, 
tobacco, raised blood pressure and salt as the main targets of preventive programmes. The 
strategy is limited by (a) referring exclusively to known risk factors, (b) excluding highly 
prevalent conditions that limit individual functioning, such as cognitive decline and 
musculoskeletal disorders, and (c) not accounting for the social structure that underpins the 
distribution of known risk factors and the effectiveness of preventive strategies and policies.  
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A considerable amount of evidence shows that socioeconomic factors are as important as 
lifestyle-related risk factors, and chemical and physical agents, in determining healthy ageing 
(House, J.S. et al, 2005; Kelly-Irving, M. et al, 2013, Stringhini, S. et al, 2010, 2017;). Low SES 
is one of the strongest predictors of healthy ageing in Europe, where, on average, disability-
free life expectancy at age 65 is 4.5 years shorter in the lowest SES group than in the highest 
group (Majer, I.M., Nusselder, W.J., Mackenbach, J.P. and Kunst, A.E., 2011). Differences in 
the actual life expectancy to age 65 in the US are even larger because social conditions predict 
a higher likelihood of premature death due to violence or unintentional injury (Muennig, P., 
Fiscella, K., Tancredi, D. and Franks, P, 2010). 
 
4. Biological pathways linking determinants to healthy ageing 
What is missing in linking overarching determinants of SES with health and poor ageing is an 
understanding of the intermediate mechanisms and pathways that relate low SES with 
deterioration of organic parameters. For example, research on immune markers in the 
Whitehall II study [Appendix 1] has shown that glucocorticoids (a class of steroid hormones) 
and inflammation may in part explain how the body mediates the effects of low SES thus 
leading to disease, and this is partly independent of common known risk factors (Stringhini, 
S. et al, 2013). More generally, recent studies have shown that SES can influence the global 
physiological dysregulation across the life-course, measured using allostatic load, a measure 
of biological multisystem wastage (Barboza Solís, C. et al. 2015; Delpierre et al, 2016 Merkin,  
S.S. et al. 2014; Nicod, E. et al. 2014).  
A research approach based on intermediate biomarkers is more powerful in identifying the 
links between SES and healthy ageing than one based on traditional risk factors alone because 
(a) it may explain subtle chronic effects acting throughout the life-course (like chronic stress) 
that are not easily captured by questionnaire-based epidemiology; (b) it allows tracing signals 
that start in early life through to health effects in later life; (c) it provides an approach to the 
discovery of new pathways and causes of disease, particularly through the new omic 
technologies (Box 1). By analysing intermediate biomarkers potentially involved in various 
diseases, this approach is likely to reveal some common (currently unknown) roots of many 
NCDs (multi-morbidity), thus improving our ability to implement successful interventions, 
with a wide range of actions.  
 
8 
 
 
Research strategy 
1. Aims of the project 
The specific objectives of LIFEPATH are:  
- To demonstrate that healthy ageing is highly variable in society, due to multiple 
environmental, behavioural and social circumstances that affect individual life 
trajectories.  
- To improve the understanding of the mechanisms through which healthy ageing 
pathways diverge by social circumstances, by investigating life-course biological 
pathways using omic technologies.  
- To provide evidence on the reversibility of the poorer ageing trajectories 
experienced by individuals exposed to the strongest adversities, by using an 
experimental approach (randomised experiments of an earned income tax credit 
programme in New York and Atlanta and a "conditional cash transfer" experiment 
for poverty reduction in New York City carried out by MDRC, the Manpower 
Demonstration Research Corporation); and to analyse the health consequences of 
the current economic recession in Europe (i.e. changes in social and economic 
circumstances).  
- To provide updated, relevant and innovative evidence to inform future policies. 
 
The project objectives will be accomplished by using different data sources:  
 Europe-wide and national surveys (updated to 2014), including EU-27; 
 Longitudinal cohorts (across Europe) with intense phenotyping and repeat biological 
samples; 
 Other large cohorts with biological samples  
 A large registry dataset with over a million individuals and very detailed information 
on work trajectories and health; 
 A randomized experiment on conditional cash transfer for poverty reduction in New 
York City.  
 A randomised experiment of an earned income tax credit programme in New York and 
Atlanta 
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 Publicly available cohort data. 
 
The geographic location of the studies is shown in Figure 2.  A detailed description of the 
cohorts and corresponding datasets is presented in Table 1 (Appendix 1) (not including 
Europe-wide national surveys). Data are harmonized and integrated to conceptualize healthy 
ageing as a composite outcome at different stages of life, resulting from life-course 
environmental, behavioural and social determinants. 
(Figure 2 here) 
2. Cohorts participating in the study 
LIFEPATH includes information and biological samples from 8 longitudinal population-based 
cohorts with extensive phenotyping and repeat biological samples, 9 large longitudinal 
population-based cohorts with biological samples, and a very large cohort without biological 
samples (WHIP, Work and Health Histories Italian Panel, from Italy). The countries that are 
covered by the cohorts are France, Italy, Portugal, Ireland, UK, Finland, Switzerland and 
Australia. These cohorts are only a small proportion of all cohorts available in Europe, but we 
have chosen them for the combination of good measures of socio-economic status, risk 
factors for NCD and biomarkers already measured (or availability of blood samples for further 
testing). The majority of cohorts include “hard” outcomes (diabetes, cancer, cardiovascular 
disease - CVD, total mortality), and the extensively phenotyped cohorts also include several 
measurements of the functional components of healthy ageing, including frailty, impaired 
vision, cognitive function, renal and brain function, osteoporosis, sleep disturbances and 
mental health. All age groups are represented with two birth cohorts, one cohort of 
adolescents and several cohorts encompassing young adults (age 18 and above). 
Furthermore, there is a strong representation of elderly subjects in 7 cohorts (Appendix 1. 
Table 1). This age structure allows us to address the first challenge, the lifecourse perspective 
(model described in Figure 1). 
 
3. Experimental studies to test policy strategies 
Data from cohorts are complemented by data from the evaluation of two randomised 
experiments in the United States carried out by MDRC (Non-profit research organisation 
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working to improve programs and policies affecting people with low SES) in New York: (a) the 
Opportunity NYC–Family Rewards study, a randomized experiment of conditional cash 
transfers (CCT) to help families break the cycle of poverty, and the first CCT program in a high-
income country. The program was evaluated through a randomized controlled trial involving 
approximately 4,800 families and 11,000 children, half of whom could receive the cash 
rewards if they met the required conditions, and half who were assigned to a control group 
that could not receive the rewards. Data include extensive measures of social and economic 
conditions as well as extensive health assessments, which the present project plans to 
complement with additional biological measures. (b) The Paycheck Plus, a randomized 
experiment of tax credits to help adults without dependent children break the cycle of 
poverty. The Earned Income Tax Credit is a federal program in which low-income individuals 
and families receive an annual credit that varies according to their working income. The 
program was evaluated through a randomized controlled trial involving approximately 10,000 
participants, with control participants assigned to the current maximum $500 annual return 
and experimental participants assigned to a maximum $2000 return. Data include extensive 
measures of social and economic conditions and we will collect data on serum cholesterol, C-
reactive protein (a marker of inflammation), glycosylated haemoglobin (a marker of diabetes), 
blood pressure, abdominal circumference, height, and weight after the intervention.  These 
experimental studies are relevant to the second challenge, the complexity of causal 
relationships and the demonstration of reversibility of some effects. 
 
4. Outcomes and definition of healthy ageing  
Indicators of healthy ageing are being developed using the wealth of individual information 
collected in the cohorts participating in LIFEPATH (Appendix 1. Table 1) as well as from publicly 
available datasets. Four “hard” indicators of healthy ageing are being used (incident diabetes, 
cancer, cardiovascular disease, and death), and several functional and physiological indicators 
are also available (blood pressure, anthropometry, frailty, physical strength, walking speed 
and grip strength, eye macular health, sleep, cognitive function including dementia, mental 
health, bone health, renal function, urinary electrolytes and cardiometabolic measures). The 
World Health Organisation increasingly emphasizes the need to shift from a definition of 
health based on hard indicators like mortality and diseases, to ability and disability indicators. 
In addition to being analysed separately, in LIFEPATH these measures will be incorporated 
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into composite indicators of (un)healthy ageing. The contribution of each outcome to the 
composite indicators will be weighted based on the severity of the outcome (with premature 
death having the highest weight). To achieve this, we will incorporate methods and estimates 
from other projects such as the Global Burden of Diseases Collaboration (Lim, S.S. et al, 2012), 
taking into account life stages and gender. Because the GBD system is controversial, we will 
also test other systems of weighting such as those based on mobility, impairment of usual 
activities, pain/discomfort and anxiety/depression derived from a systematic review of the 
literature. Early-life health events (such as sleep disturbances and changes in blood pressure) 
will be separated from typically late-life problems like frailty, osteoporosis, macular and 
cognitive impairment.    
 
In LIFEPATH we have operationally defined healthy ageing with two components. First, 
through a general statement about healthy ageing and second, through recommendations 
about variable selection and choice of analyses across the life-course using longitudinal 
datasets; these are provided below:  
 Statement on Healthy Ageing: “Healthy ageing is the optimal state of performance and 
wellbeing capable for each particular phase of the lifecourse that can be expected in a 
society, across social and cultural groups of a population”.  
 Key to variable selection is that the component variables be: a) appropriate to the life-
course stage, and b) the wellbeing variables capture something of perception and lived 
experience. 
 
5. Risk factors and healthy ageing 
One of the leading hypotheses of LIFEPATH is that SES operates partially through an unequal 
distribution of conventional risk factors for poor health across SES strata, but that there is 
also an additional effect of SES on healthy ageing that is not explained by these conventional 
risk factors (third challenge). Therefore, having good information on a number of risk factors 
for disease is key to ensuring the success of the project. Also crucial, is the ability to 
encompass the whole trajectory that links SES with healthy ageing by modelling risk factors 
(and omics, see below) with proper analytic tools and study designs. These include mediation 
analysis, structural equation models, randomized experiments and natural experiments. Once 
the data are harmonized across cohorts, LIFEPATH will assess:  
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(a) the relationship between SES measures and risk factors;  
(b) the relationship between individual risk factors for poor health and their 
combinations with multiple diseases and (composite) indicators of healthy ageing;  
(c) the intermediate role of risk factors in the relationship of SES with healthy ageing 
(including interaction between risk factors);   
(d) the proportion of the variance in healthy ageing that remains unexplained by 
measured risk factors. 
6. Biological embedding and omic biomarkers over the life span 
Differentiating the analysis of ageing in terms of the two stages of build-up and decline allows 
an appropriate and detailed exploration of ageing mechanisms, and the use of iterative 
biological measures from cohorts at different ages. For example, an analysis of the first ‘build-
up’ stage may use as its embodiment measure a biological indicator collected in childhood or 
early adulthood; whereas an analysis of the ‘decline’ stage may treat mid-life biological 
indicators as mediating variables, and measures of physical functioning in later life or diseases 
as an outcome. This dynamic approach to life-course analyses is central in LIFEPATH and will 
be made possible by the integrated use of longitudinal cohorts capturing different life stages 
with repeat measures and biological samples.  
(Box 1 here) 
___________________________________________________________________________ 
Box 1. What are omics technologies? 
Omic technologies allow us to measure the whole set of compounds in a certain compartment 
(e.g. proteomics is about all proteins). These are the definitions of the omics available or 
measured de novo in LIFEPATH: 
 
Epigenomics: The analysis of epigenetic changes in DNA, histones, and chromatin that 
regulate gene expression. Epigenetic changes are changes other than changes in DNA 
sequence that are involved in gene silencing. 
 
Metabolomics: The scientific study of small molecules (metabolites) that are created from 
chemicals that originate inside the body (endogenously) or outside the body (exogenously). 
For purposes of the present report, metabolomics is assumed to include exogenous chemicals 
found in biological systems in their unmetabolized forms.  
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Proteomics: The analysis of the proteins produced by cells, tissues, or organisms. Analysis is 
conducted to understand the location, abundance, and post-translational modification of 
proteins in a biological sample. 
 
Transcriptomics: Qualitative and quantitative analysis of the transcriptome, that is, the set of 
transcripts (mRNAs, noncoding RNAs, and miRNAs) that is present in a biological sample. 
___________________________________________________________________________ 
By combining existing information from birth and adult longitudinal studies, LIFEPATH is 
organised into three main interacting streams, illustrated in Figure 3:  
 
(a) an outer layer of the project: overarching DETERMINANTS. The focus is on healthy 
ageing as a continuous process in life ("life-path") and on SES differentials as key 
determinants, based on the well-documented assumption that SES over time is one of the 
strongest predictors (and also a summary measure) of the development and preservation of 
good health and of later-life diseases and disabilities;  
(b) a middle layer of the project: RISK FACTORS. The project studies the influences 
SES has on healthy ageing and life expectancy via behavioural, occupational, nutritional, 
environmental and other modifiable risk factors for poor health, from childhood to 
adulthood;  
(c) an inner layer of the project: BIOLOGICAL PATHWAYS and human social genomics.  
(Figure 3 here) 
Omics data (in particular epigenomics, metabolomics and transcriptomics), is already 
available in several cohorts, and is being used to follow and compare the lifetime ageing 
pathways of individuals in different SES groups or with different exposure to risk factors from 
across the life-course. This will allow us to reconstruct biologically-embedded life-course 
ageing trajectories through the integration of (i) early- and later-life SES and risk factors, and 
(ii) early- and later-life omic measurements and markers of inflammation or immune 
response.  
The scheme in Figure 3 explains the different components and outcomes of the project, as 
well as the types of biomarkers that can be developed as intermediate steps between socio-
economic status (SES), risk factors and unhealthy ageing: (a) epigenetic markers, both short-
term (and amenable to modification), and long-term (irreversible changes that can be 
attributed to early-life and late-life exposures); (b) markers of stress and HPA-axis 
14 
 
dysregulation (hypothalamic–pituitary–adrenal axis, a major neuroendocrine system); (c) 
markers of inflammation and immune response (particularly important in cardiometabolic 
disease and cancer); (d) markers of neural function and structure.   
The following biomarkers are already available or will be measured with existing funds: 
methylome (n=4,250)(see Box 1); inflammation markers (n=61,000); metabolomics 
(n=23,000)(Box 1). Most cohorts have C - reactive protein (CRP), and many have cytokines 
measurements (small proteins involved in cell signaling as immunomodulating agents).  
New methylome analyses will be performed for 2,500 new subjects and new transcriptomic 
analyses for about 600 subjects. Peripheral blood is a convenient source for epigenetic 
testing, but cellular heterogeneity can confound or mask the results (Adalsteinsson, B.T. et al, 
2012; Consortium TEP, 2012; Liu, Y. et al, 2013), because epigenetic signatures differ from 
one cell subtype to another (Reinius, L.E. et al, 2012). Moreover, the composition of the blood 
cells can change under a plethora of pathophysiological conditions, and this can also be 
influenced by SES. The importance of measuring epigenetic patterns across specific cell 
subtypes also depends on disease status, and subtle differences are likely more important for 
multifactorial traits. For these reasons, the first analyses of the methylome will be performed 
in two specific blood cell types in 500 Whitehall II subjects. We will then validate the findings 
in PBMC (peripheral blood mononuclear cell) in cohorts with cell counts available. Also, the 
biomarker stock will be enriched by measuring IL6 (interleukin that acts as pro-
inflammatory cytokine) and other cytokines in 6,600 additional subjects in Whitehall II 
(funded by the US National Institutes of Health) and in Skipogh (Table 1), in which also the 
methylome and RNA sequencing will be measured (n=750).  
In some cohorts we also have genetic data (Appendix 1. Table 1). This allows three types of 
analyses: first, we can measure the relative importance of genetic predisposition to disease 
vs environmental variables including SES; second, we can look at gene-environment 
interactions with our non-genetic variables including SES (low-penetrance susceptibility); 
third, we can apply the concept of Mendelian Randomization, i.e. identify gene variants that 
are associated with intermediate factors that connect SES with health outcomes, and 
reinforce causal reasoning (given that no genetic variants have been clearly identified that 
directly influence SES  itself). Genotyping will be performed (or is already available) through 
other funds for 17,000 subjects from Airwave, 6,600 from Whitehall II, 1,100 from Skipogh 
and 6,000 from Colaus (Table 1).  
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7. Statistical Methods 
This project is working towards developing novel statistical models integrating the different 
features determining healthy life trajectories. Statistical models are designed to (a) test 
different conceptual pathways to (un)healthy ageing, integrating information from risk 
factors, SES, omics and outcomes that contribute to healthy ageing; (b) provide estimates of 
the weight of different causes, distal/fundamental or proximal, to enable the simulation of 
different scenarios of public health policies or interventions which might improve healthy 
living.  
(Table 2 here) 
An outline of the different aspects of statistical analyses is provided in Table 2. Statistical 
methods are also being developed to investigate the association between SES and healthy 
ageing, between SES and risk factors, and between risk factors and healthy ageing indices as 
conceptualised above. Additional methodological efforts will rely on the development of 
omics profiling techniques integrating data arising from different platforms, and mechanistic 
models investigating the interplay of these different sets of markers. 
Omic signatures - As summarised in Table 3, numerous analyses rely on the identification, 
from high dimensional omics profiles, of potential omic signatures of SES-related 
exposures/patterns. 
Biological mechanisms – The full exploration of biological mechanisms involved in the SES-
affected regulatory cascades relies on in-depth exploration of the correlation structures and 
the potential effect mediations among the candidate markers found within and across the 
different platforms. 
Time-related patterns - In order to exploit longitudinal data available in LIFEPATH, specific 
time-related patterns are sought, which are predictive of the quality of ageing. 
Conceptual model of ageing and predictive score - At the end of the process, LIFEPATH will 
construct a holistic conceptual model of ageing by confronting it in an iterative way to data 
from cohorts involved in the project. This model will integrate the three layers (outer: 
16 
 
determinants; intermediate: risk factors; inner: biomarkers and omics), so that plausible 
evidence-based pathways encompassing the layers can be built.  
 
8. Age and sex/gender disparities  
From birth onwards, a sex-based mortality divide is present, with males having a greater 
mortality risk than females. Conversely, women have longer life-expectancies but live with 
higher rates of morbidity and disability. These differences vary in their nature across the 
lifespan. Sex and gender are central to any research into the processes of ageing, healthy or 
otherwise. The difficult task in disentangling sex and gender has been highlighted in 
epidemiology by Krieger (2003) who advocates more complex formulations such as “biologic 
expressions of gender” and “gendered expression of biology”. Here, we conceptualise sex/ 
gender “as a domain of complex phenomena that are simultaneously biological and social, 
rather than a domain in which the social and biological “overlap”” (Springer, K.W., Hankivsky, 
O. and Bates, L.M., 2012). 
 
Policy aims 
LIFEPATH is devoted to develop policy implications of the scientific findings. Early work in this 
project will develop conceptual models of the intermediate mechanisms and pathways 
through which SES gradients influence organic parameters. These models will be empirically 
examined using data from the study countries to produce evidence of the importance of 
different pathways in explaining SES inequalities in chronic disease occurrence. In particular, 
we are interested in the reversibility of certain biological changes (such as inflammation and 
epigenetics), and in the identification of sensitivity windows in the life course that may inform 
policies. For example, many policy interventions to mitigate the effects of poverty have so far 
addressed elderly people, but evidence is emerging that children and even foetuses are 
susceptible to the multiple effects of low SES (Kramer, M. S., Seguin, L., Lydon, J. and Goulet, 
L., 2000), and early damage can be carried on to the adult life. The LIFEPATH project takes the 
innovative step of combining biomarker results with the existing scientific and policy 
literatures, with the aim of developing a health impact assessment framework (HIA) which 
will allow the research team to simulate the impact of different policy choices on the overall 
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occurrence of disease and its distribution across different SES groups. A number of HIA models 
for specific disease groups are already available. These will be further developed to capture 
healthy ageing using the results from the LIFEPATH project. In particular, a model using 
Markov chains has been developed by the Erasmus group (DynamoOHIA) for application to 
routine data. The model can be expanded and enriched with socio-economic variables from 
the LIFEPATH cohorts and it can be tested among the different European cohorts. 
 
Early achievements so far 
We describe here a few early achievements of the project that support some of the basic 
assumptions and respond to the first challenges we have identified in LIFEPATH.  
 
 
 
 
1. SES variables and harmonization  
The LIFEPATH consortium brings together data from early life and adult European cohorts 
with intense phenotyping and repeat biological samples, other large cohorts with biological 
samples and a large registry dataset with over a million individuals and very rich information 
on work trajectories and health (D’Errico, A. et al, 2017). To merge and analyse together data 
from the different LIFEPATH cohorts, information on occupational class, education, father’s 
occupational class and income has been harmonized. The harmonization was performed in 
the initial phases of the project for each of the early life cohorts and adult cohorts 
participating in the study (Appendix 1. Table 1). Detailed codebooks have been created and 
given that SES indicators relevant for adults differ from those important to characterize 
children SES, the cohorts have been harmonised using different methods. 
 
Amongst men, the proposed three-level classification of occupational class based on the 
European Socio-economic Classification (ESeC) – higher, intermediate and lower professions 
– and education appear not to differ substantially from more detailed classifications in 
discriminating between main social strata, and in predicting differences in mortality between 
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them (D’Errico, A. et al., 2017). In spite of differences in recruitment among the cohorts, 
especially in terms of time, age, gender composition and type of sample, variability in the 
distribution of the socioeconomic indicators in the different study populations was relatively 
low. SES indicators categories observed in the different cohorts were also roughly comparable 
in their distribution to those observed in other studies conducted in Europe, including several 
conducted on representative samples of the general population. Despite the categories 
employed, both education and occupational class differed somehow from those used in the 
present study and the study populations did not share the same characteristics of those 
included in LIFEPATH. A shift toward higher occupational classes was noted between fathers’ 
and subjects’ occupations in most cohorts, which seem to reflect an increasing trend of social 
improvement in these populations.  
Strong differences in mortality between genders were observed for all SES indicators, with 
much higher and significant associations in males than females, although characterized by 
variable strength in the different cohorts (Figure 4).  
 
(Figure 4 here) 
 
2. SES as a risk factor of physiological wear and tear  
Understanding how human environments affect our health by "getting under the skin" and 
penetrating the cells, organs and physiological systems of our bodies is a key tenet in public 
health research. In LIFEPATH we examine the idea that early life socio-economic position can 
be biologically embodied, potentially leading to the production of health inequalities across 
population groups. Allostatic load (AL), a composite measure of overall physiological wear-
and-tear, could allow for a better understanding of the potential biological pathways playing 
a role in the construction of the social gradient in adult health. We have investigated the 
factors mediating the link between two components of parental socio-economic position, 
maternal education (ME) and parental occupation (PO), and AL at 44 years. Data was used 
from 7,573 members of the 1958 British birth cohort follow-up to age 44. AL was constructed 
using 14 biomarkers representing four physiological systems. We assessed the contribution 
of financial/materialist, psychological/psychosocial, educational, and health behaviors/BMI 
pathways over the life course, in mediating the associations between ME, PO and AL. ME and 
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PO were mediated by three pathways: educational, material/financial, and health behaviors 
for both men and women. A better understanding of embodiment processes leading to 
disease development may contribute to developing adapted public policies aiming to reduce 
health inequalities (Barboza Solis, C., Fantin, R., Kelly-Irving, M., and Delpierre, C. , 2016). In 
the same cohort we also showed that AL was associated with subsequent health status 
(Barboza Solis, C., Fantin, R., Kelly-Irving, M. and Delpierre, C., 2016). 
 
3. SES as a risk factor of high grade inflammation 
To explore further potential biological embedding and the consequences of socio-economic 
position experiences from early life to adulthood, we investigated how socio-economic 
position indicators at different points across the life course may be related to a combination 
of 28 inflammation markers. Using blood-derived inflammation profiles measured by a 
multiplex array in 268 participants from the Italian component of the European Prospective 
Investigation into Cancer and Nutrition cohort, we evaluated the association between early 
life, young adulthood and later adulthood socio-economic position with each inflammatory 
marker separately, or by combining them into an inflammatory score. We identified an 
increased inflammatory burden in participants whose father had a manual occupation, 
through increased plasma levels of CSF3 (Granulocyte-colony stimulating factor; β = 0.29; 
P = 0.002), and an increased inflammatory score (β = 1.96; P = 0.029). Social mobility was 
subsequently modelled by the interaction between father's occupation and the highest 
household occupation, revealing a significant difference between "stable Non-manual" 
profiles over the life course versus "Manual to Non-manual" profiles (β = 2.38, P = 0.023). Low 
socio-economic position in childhood is associated with modest increase in adult 
inflammatory burden, which is more evident for stable low SES across life (Castagne, R. et al, 
2016).  
 
Outstanding issues 
LIFEPATH is a large and ambitious undertaking, and it will try to address some of the main 
challenges in the field, but it is foreseen that some issues will remain outstanding: 
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- Measurement error is inherent in SES but also in biomarkers and omics, and this is likely 
to lead to blurring of the causal pathways 
- In spite of the development of statistical methods for mediation analysis, the complex 
(multi-layered) nature of the relationships between SES, risk factors, biomarkers and 
outcomes makes it unlikely that a complete picture can be developed. This includes the 
heterogeneity of the cohorts involved. 
- How far our inferences can be extended to other populations with a different distribution 
of risk factors, SES composition and life expectancy is unknown. 
 
Access to LIFEPATH resources 
LIFEPATH aims to become an open-access source of data for biosocial research. The central 
database contains harmonized variables for socio-economic status, risk factors, biomarkers 
and outcomes. Access will be regulated by the Steering Committee and rules for access will 
be made available to interested researchers via the Principal Investigator. 
 
Conclusions: the marriage between biology and social sciences  
Accelerated ageing and many human diseases result from a complex interaction between 
social and biological factors. Risky behaviours, occupational and environmental exposures 
and psychosocial stress are rooted in societal structures, have historical foundations, and lead 
to alterations in physiological states (such as allostatic load) that are a prelude to overt 
disease.  The study of the interplay of social and biological factors in LIFEPATH, poses several 
challenges: 
Conceptual challenges: the definition of socio-economic differentials depends on different 
theoretical constructs that put variable emphasis on status, job position (social class), 
prestige, and other factors.  Similar challenges are encountered in biological modelling, in 
relation to the relevance of certain markers (such as DNA methylation or metabolomics) to 
the exploration of ageing trajectories. 
Practical challenges, such as the availability and harmonization of good and well measured 
descriptors of SES across the cohorts. The same challenges are encountered in biomarker 
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science, where measurements are affected by “nuisance parameters” (such as batch) and 
confounders, and also need harmonization. 
A major challenge is to avoid reductionism in the interpretation of the findings. We seek to 
establish causal relations across a spectrum that encompasses societal structures, inter-
individual relationships, socio-economic position, exposure to risk factors, and the underlying 
layers of biological mechanisms (that in turn involve whole individuals, tissues, cells and 
molecules). Causal models have been proposed separately in social sciences and in biological 
sciences, and they tend to be very different. Our ambition is to integrate them not only 
conceptually but also operationally and technically in the use of statistically modelling) 
(Vineis, P., Illari, P. and Russo, F., 2017). 
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Figure 1. The “build-up” and “decline” model. 
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Appendix 1. Table 1 – LIFEPATH: cohorts included in the consortium. Study design/cohort description 
Cohort Study design Outcomes and clinical tests Already available/funded 
biomarkers 
Whitehall II (UK) 
N=10,308 
(Stringhini, S. et al,  
2013) 
 
The Whitehall II study was established in 1985 to examine 
the socioeconomic gradient in health among 10,308 
London-based civil servants (6,895 men and 3,413 women) 
aged 35–55. Baseline examination (phase 1) took place 
during 1985–1988, and involved a clinical examination and 
a self-administered questionnaire containing sections on 
demographic characteristics, health, lifestyle factors, work 
characteristics, social support, and life events. 
 
Mortality, cancers, CVD events.  
BP, diabetes, anthropometry, 
physical functioning, cognitive 
function, mental health, 
hospitalizations.   
 
Genotype (metabochip, 
cardiochip); metabolomics 
(NMR)(n=6,600); repeat data on 
lipids, glucose, insulin, 
inflammatory markers (CRP, IL6), 
cortisol (saliva, hair) (n=6,000-
10,000). 
Subset: Brain MRI 
TILDA (Ireland) 
N = 8,175 
 (Kearney, PM et al, 
2011); 
Cronin, H., 
O’Reagan, C., 
Finucane, C., 
Kearney, P. & Kenny, 
R.A., 2013) 
The Irish Longitudinal Study on Ageing (TILDA) is a large 
prospective cohort study examining the social, economic, 
and health circumstances of 8,175 community-dwelling 
older adults (3,744 men, 4,431 women) aged 50 years and 
older at the time of recruitment and resident in the Republic 
of Ireland. Baseline examination (phase 1) took place 
during 2009-2011 and participants are followed up 
biennially.  There were three components to the survey. 
Respondents completed a computer-assisted personal 
interview (n = 8,175) and a separate self-completion paper 
and pencil module (n = 6,915) which collected information 
that was considered sensitive. All participants were invited 
to undergo a separate health assessment at one of two 
national centers using trained nursing staff (n=5,897). A 
total of 5036 respondents completed the health-centre 
BP, heart rate variability, pulse 
wave velocity, cerebral 
perfusion, balance, gait speed, 
osteoporosis, renal function, 
cognitive function, physical 
function, accelerometry, muscle 
mass, muscle strength, retinal 
imaging, macular pigment 
density, sensory performance, 
anthropometry mental health, 
quality of life, hospitalization, 
mortality, cancers, diabetes, 
CVD events, medical history, 
medications.  
Lipids (N=5,800).  
Funded: Vitamin B12, Vitamin D, 
CRP, Creatinine, Folate, HbA1c 
(N=5,800).  
Subset: Brain MRI 
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based assessment and a further 861 respondents completed 
a home-based assessment which involved a reduced set of 
tests.  A more detailed exposition of study design, sample 
selection and protocol is available elsewhere (Whelan, B.J. 
& Savva, G.M., 2013). 
Generation 21 
(Portugal) 
N=8,647 
Barros, H.,  
Correia, S. et al. BMJ 
Open 2014; 
Larsen PS et al., 2013 
 
 
Generation 21 (G 21) comprises a cohort of 8,647 
newborns recruited in 2005–2006 in the Porto 
Metropolitan Area, in northern Portugal. Recruitment 
occurred at the 5 public maternity units, which are 
responsible for 95% of all births in the region (remaining 
births occurred at private hospitals)21. During the hospital 
stay, women delivering live births were invited to 
participate, and 92% of mothers agreed. All who agreed 
were invited to be re-evaluated at child’s 4 years of age 
(2009-2011) , at 7  (2012-2014) and then again at 10 years 
(2015-2016).  
Self-reported health status 
(health conditions), Tetrapolar 
Bioimpedance, ECG, Blood 
Pressure, Spirometry, DEXA, 
cognitive test.  
CRP, lipids, glucose, insulin (4yrs 
n=1,530; 7yrs n=4,500) 
The Airwave Health 
Monitoring Study 
(UK) 
N=45,596 
Paul Elliott 
http://www.police-
health.org.uk/ 
 
Airwave Health Monitoring Study is an ongoing long term 
epidemiological occupational cohort study open to all 
police forces in UK.  The study’s current main goal is to 
investigate any possible impacts of TETRA on health by 
looking at TETRA exposure and subsequent health 
amongst police officers and staff. The study was launched 
in 2004, and since its inception, 28 out of 54 police forces 
have agreed to participate. The cohort aims to have 60,000 
participants by 2018. By December 2010, the cohort had 
recruited 42,057 participants out of which 34,957 have 
undergone a health screening that includes extensive 
Cancer, death, hospitalizations. 
Sickness absences, blood 
pressure, ECG, arterial stiffness, 
anthropometry, cognitive test on 
sub-samples. 
Blood count, haemoglobin, urea, 
creatinine, Gamma GT, lipids, 
glucose, HBA1c, C-peptide, CRP, 
fibrinogen, prothrombin time 
(N=35,000) 
Genotyping (N=17,000)  
Metabolome (N=3,000)  
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lifestyle and questionnaire data, clinical measurements and 
collection of biological samples. 
EPIPORTO 
(Portugal) 
N=2,485 
(Alves, L., Barros, H.,   
 et al., 2015)   
The EPIPorto is a general adult population-based cohort 
established with the initial aim of evaluating the major 
determinants of cardiovascular health. For this purpose, 
2,485 (949 men and 1,536 women) adult dwellers in Porto, 
aged 18 years or over, were recruited between 1999 and 
2003 using random digit dialling. The follow-up studies 
were performed for the whole sample in 2005-2008, and in 
2014-2015. At all waves, information was collected using 
questionnaires administered by trained interviewers, self-
administered questionnaires and objective measurements 
were made, including physical examination and blood tests 
(Pereira et al, 2012). 
Mortality, cancers, CVD events.  
BP, diabetes, anthropometry, 
ECG, Musculoskeletal 
conditions. 
CRP, lipids, glucose, insulin, 
fibrinogen 
 
 
SKIPOGH study 
Switzerland  (3 
centres) 
N=1,128 
Bochud, M., 
Ponte, B. et al. 
Hypertension 2014 
 
The Swiss Kidney Project on Genes in Hypertension is a 
longitudinal family-based study, following the 
standardised EPOGH (European Project on Genes in 
Hypertension) protocol. Baseline examination was 
conducted between 2009 and 2013. Three-year follow-up 
examination started in 2013 and is currently ongoing 
(expected to be finished in 2015). The aim of the study is 
to explore the role of genes and kidney haemodynamics in 
blood pressure regulation and kidney function in the 
general population. From December 2009 to March 2013, 
adult participants were recruited in two regions (Berne and 
Geneva) and one city (Lausanne) of Switzerland. A random 
sample of the inhabitants was drawn using different 
strategies. Inclusion criteria were (1) having a minimum 
Deaths, CVD events, diabetes, 
hypertension, 24h BP, 
anthropometry, ECG, arterial 
properties, retinal imaging, renal 
function, chronic kidney disease, 
kidney morphology, cardiac 
imaging (3D); hand-grip 
strength. 
Methylome (Illumina 450K) 
(N=250). Transcriptomics (N=250).  
Inflammation markers, CRP, lipids, 
fasting glucose, insulin. Urine Na, 
K, urea, steroid metabolites 
(N=1,100). Cardiometabochip 
(200K SNPs) (N=1,100).  
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age of 18 years; (2) being of European ancestry; (3) having 
≥one and ideally three first-degree family members willing 
to participate; and (4) providing a written informed 
consent. Pregnant or breastfeeding women were not 
included. The general participation rate was 27.1%. At 
baseline, we collected data on cardiovascular and 
metabolic risk factors as well as on the prevalence of 
kidney and cardiovascular diseases. During follow-up, we 
are collecting data on new kidney and cardiovascular 
events. The primary endpoints are fatal and non-fatal 
strokes, ischaemic heart disease, heart failure and chronic 
kidney disease. The 1,128 participants (537 men and 591 
women) belong to 272 nuclear families. 
COLAUS Study 
N=6,733 
(Firmann, M.  et al.,  
2008) 
The CoLaus (COhorte LAUSannoise) is an ongoing 
prospective study assessing the clinical, biological and 
genetic determinants of cardiovascular disease in the city 
of Lausanne, Switzerland (Firmann et al., 2008). The initial 
survey was conducted between 2003 and 2006 and 
included 6,733 participants aged between 35 and 75 years; 
the first follow-up survey was conducted 5.5 years 
afterwards and included 5,064 participants. In each survey, 
data on socio-economic status, lifestyle, mental status and 
cardiovascular risk factors is collected by questionnaire or 
clinical examination. 
Deaths, CVD events, diabetes, 
hypertension, BP, 
anthropometry, physical and 
cognitive functioning, FFQ, 
PAFQ. 
N=2,000 polysomnography 
(Hypnolaus) 
N=3,500 psychiatric 
examination (Psycholaus) 
Inflammation markers (N=6,300), 
CRP, lipids, fasting glucose, 
insulin, vitamins, genotype (500 K 
Affymetrix chip technology) 
Growing Up in 
Ireland (Ireland) 
N = 19,702 
Longitudinal child cohort established in 2007/2008. The 
study takes place over seven years and follows the progress 
of two groups of children: 1) containing 11,134 participants 
Chronic illness of parents and 
children and whether confirmed 
by physician. 
Measured heights and weights for 
parents and children at each wave. 
35 
 
 Layte, R. and 
McCrory, C, 2013 
aged 9 months at baseline with three study waves (9 
months, 3 years and 5 years) and 2) containing 8,568 
participants aged 9 years at baseline (9 years, 13 years). 
The dataset gathered contains multiple SES measures of 
parents at each wave and economic strain and 
anthropometric measures at each wave of child and parents. 
Acute illness for infants at 
baseline. 
Child psychological adjustment, 
cognitive function, parent/child 
relationship, child self-concept. 
Measured head circumference for 
9-month cohort at baseline.  
 
 
 
Other large longitudinal cohorts with biological samples (n=202,555). 
Cohort  Study Design Outcomes and clinical trials Already available/ funded 
biomarkers 
EPIC- Italy 
N=47,749 
Gallo, V. et al, PLoS 
One 2012  
The European Prospective Investigation into Cancer and 
Nutrition (EPIC) is a large European study on diet and 
cancer. The Italian component of EPIC EPIC-Italy) 
recruited 47,749 adult volunteers (men and women) at five 
centres: Varese and Turin in northern Italy, Florence in 
central Italy and Naples and Ragusa in southern Italy. All 
participants signed an informed consent form and 
completed two questionnaires: one about dietary habits 
(food-frequency) and one about lifestyle, with information 
on education, socioeconomic status, occupation, history of 
previous illnesses and surgery, lifetime tobacco use and 
alcohol consumption and physical activity. EPIC database 
records were linked to cancer and regional mortality 
All cancers, CVD, diabetes, BP. Methylome (Illumina 450K) for 
>1,000 subjects. 
Inflammation markers, CRP, 
lipids, in subsets 
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registries after EPIC database quality control. All EPIC-
Italy centres except Naples are covered by population-
based cancer registries. In Naples, follow-up information 
was collected from electronic hospital discharge records 
and also by periodic personal contact with participants. We 
are including in LIFEPATH centres from EPIC Italy 
(N=34,148) with the exclusion of Florence. 
E3N (France) 
N=98,995 
 
(Dartois., L., 
Fagherazzi, G., 
Boultron-Ruault, M.C., 
Mesrine, S. and Clavel-
Chapelon, F. 2014) 
The E3N study (Étude Epidémiologique auprès de femmes 
de la Mutuelle Générale de l’Education Nationale) is a 
prospective cohort of 98,995 women aged 40-65 years at 
recruitment in 1990 and it constitutes the French 
component of EPIC. The study was established to produce 
a large mass of data relevant for the identification of 
environmental and molecular causes of cancer and other 
chronic diseases, and to contribute to the development of 
effective public health strategies. Data on residence, 
education, early life events, exposures, lifestyle factors and 
life events were collected at baseline and follow-up 
questionnaires were sent every 2-3 years with more than 
80% response. Mortality data were obtained by means of 
regular record linkage with various French mortality 
databases. 
 
Self-reported health outcomes 
at each questionnaire. All 
cancers (verified), CVD, 
diabetes, asthma, osteoporosis, 
depression, migraine 
 
Metabolomics data on 800 breast 
cancer cases, 800 controls. B-
vitamins 1,000 samples, 1,800 
samples, Fatty acids 1,700 samples 
NCDS (British 1958 
Birth Cohort Study) 
N= 18,555 
The National Child Development Study (NCDS) is a birth 
cohort established in 1958, which follows the lives of over 
17,000 people born in England, Scotland and Wales in a 
single week in 1958. The participants to the study are 
Self-reported health outcomes 
at each sweep (CVD, Cancer 
etc). All-cause mortality from 
register to 2008. Biomedical 
Biomarkers from biomedical 
survey at age 44-46y (lipids, IGE, 
HbA1c, IGF, CRP, Fibrinogen, 
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Hypponen et al, 
2005Hypponen et al, 
2005 
followed up at ages 7, 11, 16, 23, 33, 42, 46 and 50. A 
biomedical survey (for 9,377 cohort participants) was 
conducted when participants were aged 44-46 years 
(N=18,555). The datasets contains prospective SES adult 
life and early life. 
 
data from measurements (BP; 
lung function; BMI)  
 
Von Willebrand). Subset: 
metabolomics data (N=8,000). 
Understanding society  
N=40,000 households 
(Shiue, I.l, 2014) 
Understanding Society is an innovative UK household 
longitudinal panel study established in 2008 (population-
based households sample). This study captures 
information about the 21st century UK life, looking 
specifically at its participants’ social and economic 
circumstances, attitudes, behaviours and health. 
Information is also collected on all new household 
members. The data contains information related to SES 
adult and early life. 
Self-reported health data on 
20,000 individuals. Biomedical 
data from nurse visit (6,104).  
 
Blood sample, Saliva sample 
(details of analytes not released 
yet) 
Gazel (France) 
N= 20,625 
(Westerlund, H., 
Kivimaki, M., Singh-
Manoux, A., Melchior, 
M., Ferrie JE., Pentti, J., 
Jokela, M., 
Leinewebber, C., 
Goldberg, M., Zins, M. 
and Vahtera, J.,2009) 
The GAZEL study was established in 1989 among 
employees of the French national gas and electricity 
company, Electricité de France-Gaz de France (EDF-GDF) 
(Goldberg et al., 2007, 2015). At baseline (1989), 20,625 
employees (15,011 men and 5,614 women), aged 35–50, 
gave consent to participate. The study design consists of an 
annual questionnaire used to collect data on health, 
lifestyle, individual, familial, social and occupational 
factors, and life events. 
Mortality, cancers, CVD events.  
Diabetes, asthma, depression, 
sleep disturbances, migraine, 
quality of life, cognitive and 
physical functioning. 
Systematic individual linkage to 
health insurance, hospital 
discharge, retirement and 
mortality national database. 
Blood samples (serum, plasma, 
buffy-coat) for about 5,000 
subjects 
Constances 
N (by 2017)= 200,000 
The CONSTANCES cohort was established in late 2012 
(Zins et al., 2015). It was designed as a randomly selected 
Mortality, cancers, CVD events.  
Diabetes, asthma, depression, 
Blood count, glucose, lipids, 
creatinine, GGT (N=35,000) 
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May 2016 N: 100,000  
Zins, M.,  Goldberg, M. 
and  Berkman, L.,  et al, 
BMC Public Health. 
2010 
representative sample of French adults aged 18-69 years at 
inception; 200,000 subjects will be included over a five-
year period. At enrolment the participants fill 
questionnaires collecting data on health, lifestyle, 
individual, familial, social and occupational factors, and 
life events and benefits from a comprehensive health 
examination. The follow-up includes a yearly self-
administered questionnaire, a health examination every 5 
years and an annual linkage to social and health national 
databases. 
sleep disturbances, migraine, 
quality of life, cognitive and 
physical functioning. 
Systematic individual linkage to 
health insurance, hospital 
discharge, retirement 
(occupational history) and 
mortality national databases. 
MCCS study (Cancer 
Council Victoria, 
Melbourne) 
N=41,514 
Giles, G.,  
Hodge, A. et al, 2013 
The Melbourne Collaborative Cohort Study is a 
prospective cohort study of 41,514 participants (24,469 
women) living in Melbourne, Australia. Caucasian 
volunteers aged between 40 and 69 years were recruited in 
randomly selected census districts. At baseline (1990–
1994), participants attended clinics where demographic, 
lifestyle and dietary information were collected and 
anthropometric measurements were performed. 
Verified cancer diagnoses, 
deaths with cause of death, 
CVD, diabetes, obesity (through 
physical measures at second 
visit) 
Methylome (Illumina 450K) for 
3,000 subjects.  
Inflammation markers for 500 
controls, fatty acids for 1,000 
controls. Glucose and lipids for 
23,000. 
EPITEEN (Portugal) 
Henrique Barros 
N=2,942 
Ramos, E. et al. 
ActaPaediatr 2007 
Epidemiological Health Investigation of Teenagers in 
Porto is a random sample of 2,942 adolescents enrolled at 
public and private schools in Porto, Portugal. The first 
wave was completed in 2003-2004 when participants were 
aged 13 years. The second wave in 2007-2008 (17 years), 
the third wave in 2011-2013 (21 years) and the fourth wave 
in 2014-2015 (24 years).   
Self-reported health outcomes 
(diseases diagnosis), BP, 
Anthropometry, Spirometry, 
Bioelectrical impedance , Bone 
health (forearm dual-energy X-
ray absorptiometry), ECG 
(21yrs) 
CRP, lipids, glucose, insulin 
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In addition to the cohorts shown in the table we will also use a large cohort called Work History Panel (WHIP). WHIP is based on a sample of individual-
level data from the Social Security Administration archives in Italy, covering almost 8% of all Italian workers employed in the private sector in 1985-
The Cardiovascular 
Risk in Young Finns 
Study (Finland) 
Olli Raitakari 
N=3,596 
(Raitakari, O. et al., 
2003) 
The Cardiovascular Risk in Young Finns Study (YSF) 
collected data on 4,320 children and adolescents aged 3, 6, 
9, 12, 15 and 18 years at baseline who were randomly 
chosen from the population register of five Finnish cities 
with universities with medical schools to produce a 
representative sample of Finnish children. Of those invited 
(N=4,320), 3,596 (83%) participated in the first cross-
sectional study in 1980. Between 1980 and 1992, these 
cohorts were followed up at 3-year intervals. The follow-
up field studies were performed for the whole study 
population in 1983 and 1986, when 2,991 (83.2%) and 
2,799 (78.3%) subjects participated.  In 1989 and 1992 
questionnaires were sent to every individual, but only a 
subset of individuals had their height measured in these 
survey years so we omit these observations from the 
analysis. In 2001, 2,283 subjects (63.5%) of the original 
cohort participated in clinical examinations. A detailed 
description of the sample can be found elsewhere22.  For 
the purposes of this analysis, we treat YFS as 6 different 
cohorts representing 3-year age bands (3, 6, 9, 12, 15, and 
18 years of age upon recruitment into the study).   
 
Morbidity, mortality, self-
reported health outcomes, BP, 
Anthropometry, Cognitive 
functioning 
CRP, lipids, glucose, insulin, 
GWAS, metabolomics 
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2010. Unlike all other cohorts in Table 1 it does not have biological samples, but it provides very rich information on income, pensions, unemployment 
benefits, disability indemnities, workplace and job contracts, linked to hospital and mortality follow-up (see box below). 
 
 
Cohort  Study design Outcomes and clinical tests Already available/funded 
biomarkers 
Work History 
Panel (WHIP)  - 
Health 
Italy - N=1,364,922 
 Costa, G., 
Leombruni, R. et al, 
Epidemiol & Prev 
2010 
The Work History Panel is based on a sample of individual-
level data from the Social Security Administration archives in 
Italy, covering almost 8% of all Italian workers employed in 
the private sector in 1985-2010. Unlike all other cohorts in 
LIFEPATH, it does not have biological samples, but it 
provides very rich information on income, pensions, 
unemployment benefits, disability indemnities, workplace 
and job contracts, linked to hospital and mortality follow-up. 
Mortality and hospitalization by 
cause (2001-2012). 
 
 
Not available. 
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 Figure 2 - Map of the Adult & Child Cohorts participating in LIFEPATH 
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 Figure 3. The role of biomarkers in biological pathways leading from SES to healthy 
ageing. 
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Table 2 – Statistical analyses involved in LIFEPATH 
Task Aim/ Data Expected outcome relevant 
to LIFEPATH 
SES and exposure 
variables vs health 
outcomes  
Aim: Harmonize and 
analyze different indicators 
of SES available in the 
cohorts; build a composite 
indicator of SES; analyse 
exposure variables. 
Harmonize and analyze 
health outcomes and build 
indicators of healthy ageing  
 
Analysis of all cohorts 
yielding estimates of:  
- Association between SES 
measures and healthy ageing 
variables  
- Association between SES 
variables and risk factors  
- Adjustment of SES-
outcome relationships by risk 
factors  
 
Identification of internal 
markers of SES  
Aim: Identify in the 
untargeted –omic profiles 
which candidates are 
correlated to SES  
List of putative internal 
markers of SES 
(methodologically validated)  
Implementation of Life-
course disease risk models  
Aim: Identify markers of 
SES/exposures also relating 
to the healthy ageing 
outcomes, and elucidate how 
their effect is mediated by 
critical stages in life (early vs 
late)  
Quantified predictive 
abilities of the validated 
markers. Estimates of the 
age-related susceptibility 
functions, and identification 
of potential critical age 
ranges at which 
SES/exposures are 
influential with regard to the 
disease risk.  
Burden of disease 
calculations SES-based 
risk score 
Aim: Estimate the Burden of 
disease using refined risk 
estimates based on SES, 
external exposures and 
omics. 
 
Aim: Develop a prototype 
for a SES-based score for the 
prediction of unhealthy 
ageing.  
Updated estimates of the 
burden of disease for selected 
exposures.  
 
 
To assess whether the 
additional predictive ability 
associated with SES 
measures can be 
incorporated into policies 
and clinical work.  
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Figure 4 - Meta-analysis of the association of mortality with education, by gender 
(d’Errico et al, PLOS ONE, in press) 
 
                      Figure 4 - Meta-analysis of the association of mortality with education and occupational class, 
 by gender  
(d’Errico et al, PLOS ONE, in press 
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